Black Bird Biotech, Inc.: M&A transaction — Black Bird Biotech control changes to Nelson W. Grist; he becomes CEO

Black Bird Biotech, Inc.

Grist acquires ~55.95% of Series A Preferred from four directors for $75K (cash + notes).
Upon closing, Grist will hold ~46.83% voting control via ownership and voting agreement.
All current directors expected to resign; Grist to be sole Director.
Grist appointed CEO effective March 4, 2024; prior CEO of For the Earth Corp. and Perk International.

item 5.01 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Nelson W. Grist

Chief Executive Officer

Black Bird Biotech, Inc.

Effective: 2024-03-04
Filed: March 5, 2024, 6:59 PM ET

Effective March 4, 2024, the Board of Directors of the Company appointed Nelson W. Grist as Chief Executive Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Nelson W. Grist was appointed as Chief Executive Officer at Black Bird Biotech, Inc..

Action: appointed
Role: Chief Executive Officer

Exact text from the filing

Effective March 4, 2024, the Board of Directors of the Company appointed Nelson W. Grist as Chief Executive Officer.

View on SEC.gov

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.4

Black Bird Biotech, Inc. underwent a change of control involving Nelson W. Grist (closed 2024-03-15).

Action: change of control
Counterparty: Nelson W. Grist
Closing: 2024-03-15

Exact text from the filing

Upon the closing of the Series A Agreements, which is expected to occur on or after March 15, 2024.

View on SEC.gov

21 m&a transactions filed in the last 30 days. Browse all m&a transactions →

Source: SEC EDGAR

accession 0001477932-24-001034

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.